Business Context and Reporting Period
Company: Phibro Animal Health Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: February 4, 2025
Reporting Period: Event date of February 4, 2025
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is a current report focused on a specific corporate action rather than periodic financial performance.
Material Changes
The material event reported is the declaration of a quarterly cash dividend. There are no reported changes to financial results or operational status in this filing.
Guidance, Outlook, and Management Commentary
Dividend Declaration: The Board of Directors declared a quarterly cash dividend of $0.12 per share on Class A and Class B common stock.
Record Date: March 5, 2025
Payment Date: March 26, 2025
Outlook: The filing contains no forward-looking guidance, risk updates, or management commentary beyond the dividend announcement.
Investor Verification Checklist
- Verify the ex-dividend date (typically the business day before the record date of March 5, 2025) to determine eligibility for the $0.12 per share payment.
- Confirm the payment date of March 26, 2025, for cash flow planning.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the dividend policy.
- Note that this filing does not contain updated financial statements; refer to the most recent 10-Q or 10-K for financial health metrics.